Poland – Pharmaceutical products – SUPPLY OF VARIOUS MEDICINAL PRODUCTS ACCORDING TO 175 PACKAGES
1. The subject matter of the contract is the supply of various medicinal products according to 175 packages to the Contracting Authority's premises (Kraków, os. Złotej Jesieni 1), in accordance with the description and requirements contained in Annex No. 1 to this specification. 2. For cytotoxic
Opportunity description
1. The subject matter of the contract is the supply of various medicinal products according to 175 packages to the Contracting Authority's premises (Kraków, os. Złotej Jesieni 1), in accordance with the description and requirements contained in Annex No. 1 to this specification. 2. For cytotoxic medicinal products/monoclonal antibodies, the Contracting Authority requires the tender to include the data required in the SWZ, in particular in Annex No. 1 to the SWZ, concerning the density of solutions or the mass of excipients. 3. The shelf life / warranty period of the subject matter of the contract may not be shorter than 12 months from the date of delivery, and for nutritional products – shorter than 12 months, but not shorter than 6 months. Deliveries of products with a shorter shelf life may be permitted in exceptional situations, and each time consent for them must be given by an authorized representative of the Contracting Authority, with confirmation by e-mail. 4. In drug programs and chemotherapy, only medicinal products included on the NFZ reimbursement lists are permitted (the price of the medicinal product may not exceed the financing limit established by the NFZ). 5. When specifying a form in the Specification, e.g. “tabl.”, the Contracting Authority means all types of tablets; “kaps.” means all types of capsules, etc.; in other cases, the form is specified precisely: e.g. “enteric-coated tablet” means that only an enteric-coated tablet is permitted. 6. Medicinal products constituting part of the subject matter of the contract shall be understood as medicinal products within the meaning of the Pharmaceutical Law Act of 6 September 2001 (consolidated text: Journal of Laws of 2025, item 750, as amended). The medicinal product offered must be authorized for marketing under the rules set out in Article 3 or Article 4(1) and (2), or Article 4a of the Pharmaceutical Law Act. 7. The foodstuffs for particular nutritional uses offered, constituting part of the subject matter of the contract, must meet the relevant requirements and be authorized for marketing under the rules set out, in particular, in the provisions of the Act of 25 August 2006 on Food and Nutrition Safety (consolidated text: Journal of Laws of 2023, item 1448, as amended) and implementing acts, including the Regulation of the Minister of Health of 16 September 2010 on foodstuffs for particular nutritional uses (consolidated text: Journal of Laws of 2015, item 1026). 8. In the performance of this contract, in the part concerning the transport of products to the Contracting Authority's premises, the Contracting Authority permits the participation of subcontractors holding the required authorizations. 9. The remaining contract conditions are specified in the draft contract constituting Annex No. 3 to the Specification. The subject matter of the contract is the supply of various medicinal products to the Contracting Authority's premises (Kraków, os. Złotej Jesieni 1), in accordance with the description and requirements contained in Annex No. 1 to this specification Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.